EnergyUS
Williams seeks FERC approval for US$54.7M Leidy gas expansion
A Sept. 24 federal notice opens intervention in Transco's Pennsylvania pipeline application, while Williams targets late 2027 service.
Clearmind Medicine reports three published US patent applications
The applications pair LSD, ketamine and ibogaine with N-acylethanolamines, while the scope of any patent rights remains undecided.
CannabisPolicy
New York anti-inversion bill awaits Hochul after Curaleaf ad
Curaleaf urged a signature on Sept. 23; A10698B would let regulators seek suspensions and impose daily civil penalties.
Analysis
Cycurion expects US$843K in 2026 public-safety revenue
A CAD administration role accounts for US$57,127 of the forecast; a US$3.43M ten-year value depends on continued authorization.
Technology
CNSX: NTARNextech3D.ai reports $1M‑plus in new customer contracts
It counted 180 new customer contracts through Sept. 23 but gave no schedule for recognizing their value as revenue.
TechnologyUS
SLB wins four Aramco well contracts covering more than 450 wells
The three-year Saudi program can run two years longer, but SLB did not disclose a contract value or a first-well date.
TechnologyCyber Security
BlackBerry revenue rises 26% as QNX and licensing lift fiscal Q2
Adjusted EPS beat BlackBerry's June outlook, while the company forecast a sharp licensing revenue decline in the next quarter.
Uranium
NYSEAMERICAN: JAGUSelected historic core from Colombia also held magnet rare earth oxides, but continuity and recovery remain untested.
Uranium
CVE: FUUThe 1-for-10 plan has shareholder approval but still needs TSX Venture Exchange acceptance; Dev Randhawa becomes executive chair.
Analysis
Merck says remigromig met BRUNELLO vision endpoint, flags eye risks
Both doses passed a vision noninferiority test against ranibizumab; higher rates of retinal complications await detail.
Latest
Aurora Cannabis challenges Curaleaf bid disclosures at Alberta regulator
Aurora cites missing pro forma financials, a French-language notice and the mandatory 105-day deposit period in its ASC application.
NeoVolta Inc.'s revenue rises 58% as loss widens to US$21.5M
June-quarter sales fell to about US$13,500, while a post-year-end secured loan added US$20 million in initial funding.
Quanome Technologies signs US$18.8M GPU server order for planned AI hub
A Sept. 16 agreement covers 32 servers from Compal; Quanome targets a fourth-quarter opening but has disclosed no cloud customer.
Avanti Gold closes C$51.75M bought deal for Misisi drilling
The 103.5 million new shares fund a 42,000-metre drill program and work toward a 2027 study of the Misisi gold project.
Eli Lilly says Foundayo draws one‑third of new GLP‑1 pill patients
Ricks gave no period or patient count for the estimate as Lilly broke ground on its US$6.5 billion Houston ingredients plant.
IM Cannabis prices US$1.31M share sale as Nasdaq confirms compliance
A 51 per cent stake in a Polish drone company remains a non-binding proposal, while the registered share sale is expected to close Sept. 24.
Mentioned this week
TSECURACuraleaf Holdings
New York anti-inversion bill awaits Hochul after Curaleaf adMining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningRare Earths
Greenland Mines Ltd raises over US$42M and ends ATM financing
The Nasdaq-listed miner says it has completed Sarfartoq fieldwork and expects the financing to fund its 2027 milestones.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: ATYRThe new Phase 3 study shifts its primary measure to lung function after an earlier miss, but aTyr says it needs more money to run it.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
TechnologyBitcoin
Sequans ends bitcoin treasury after sale of last 314 coins
The company gave no sale proceeds or new cash balance, leaving its June 30 cash of US$21.0 million as the latest figure disclosed in the releases.
Technology
QSE: IGRDEstithmar Holding wins QAR500M‑plus MEEZA data-centre contract
Elegancia will deliver the Qatari facility in two phases, but the companies gave no power rating or completion date.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
TSE: CCOPEJ aims to finish negotiations by year-end 2026 for three AP1000 units totaling 3,750 MWe; the EPC price remains undisclosed.
Uranium
KRX: 028260The Sept. 21 term sheet mixes direct investment and engineering services, requires approvals and leaves Samsung's cash share and equity stake undisclosed.
Energy
NASDAQ: CBATThe signed development-zone agreement adds a counterparty, while financing still governs the new lines and a separate expansion targets year-end.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Psychedelics
CNSX: OPTIThe Health Canada-authorized depression study plans to enroll up to 200 people, while the batch also serves Australian clinics.
Cannabis
TSE: CURAThe addition gives Curaleaf a second Canadian benchmark, but its Sept. 23 release does not quantify any resulting fund purchases.
Psychedelics
NASDAQ: DFTXPanorama's week-12 result came with widespread treatment guesses; Definium plans an FDA meeting in the fourth quarter.
Cannabis
NYSE: TRLVVanguard's Extended Market Index Fund, which held US$95.4 billion on Aug. 31, tracks one of the two benchmarks that took the shares in.